• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Melitracen Hydrochloride

Melitracen Hydrochloride

Product ID M1845
Cas No. 10563-70-9
Purity ≥99%
Product Unit SizeCostQuantityStock
5 mg $92.00 In stock
25 mg $306.00 In stock
100 mg $817.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Melitracen hydrochloride is an clinically acceptable effective tricyclic antidepressant that exerts no harmful cardiac side effects, unlike many other antidepressants. This compound is often administered with flupenthixol as “deanxit,” which shows efficacy in the treatment of trigeminal neuralgia and increases quality of life ratings in subjects with functional dyspepsia. This compound is likely an antagonist at D1/2 receptors.

Product Info

Cas No.

10563-70-9

Purity

≥99%

Formula

C21H25N • HCl

Formula Wt.

327.89

IUPAC Name

3-(10,10-dimethylanthracen-9-ylidene)-N,N-dimethylpropan-1-amine;hydrochloride

Melting Point

245-248°C

Appearance

White powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

M1845 MSDS PDF

Info Sheet

M1845 Info Sheet PDF

References

Liu EJ, Zhang WL, Bai YP. [Observation on clinical efficacy of depression treated with the alliance of acupuncture and medication]. Zhongguo Zhen Jiu. 2013 Jun;33(6):497-500. PMID: 23967634.

Hashash JG, Abdul-Baki H, Azar C, et al. Clinical trial: a randomized controlled cross-over study of flupenthixol + melitracen in functional dyspepsia. Aliment Pharmacol Ther. 2008 Jun 1;27(11):1148-55. PMID: 18331614.

Bin Yaacob H. Flupenthixol and Melitracen in the management of trigeminal neuralgia. Dent J Malays. 1985 Apr;8(2):37-8. PMID: 3917005.

Martini C, Fici F. Acute poisoning with melitracen--absence of ECG changes. Int J Clin Pharmacol Biopharm. 1978 Mar;16(3):129-31. PMID: 649231.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • B3278

    Biotin

    Water-soluble coenzyme, vitamin (B7) found in v...

    ≥98%
  • D5753

    Donepezil Hydrochloride

    GSK3 and AChE inhibitor, potential σ1 agonist....

    ≥98%
  • P5747

    Polymyxin B sulfate

    Cationic lipid polypeptide, mixture of polymyxi...

    ≥6500 iu/mg
  • L1782

    Levodopa

    Endogenous catecholamine precursor, also found ...

    ≥98%
  • R183731

    Resiquimod

    Toll-like receptor 7/8 agonist

    ≥98%
  • S680000

    SR144528

    Selective cannabinoid receptor 2 (CB2) inverse ...

    ≥98%
  • R7680

    Recombinant M. Tuberculosis Antigen TB 38+6+10

    Tuberculosis antigen

  • G681019

    Grapiprant

    EP4 receptor antagonist

    ≥98%
  • P4132

    PKI-402

    p110α PI3K and mTOR inhibitor.

    ≥98%
  • C9614

    Cyclosporin H

    Cyclosporin metabolite; formyl peptide inhibito...

    ≥96%
  • D9752

    Dynasore

    Dynamin inhibitor.

    ≥98%
  • S881011

    Swainsonine

    Antineoplastic immunomodulator.

    ≥98%
  • C211324

    CFI-400945

    PLK4 inhibitor.

    ≥98%
  • O9256

    16-Oxocafestol

    Synthetic cafestol derivative.

    ≥97%
  • H189921

    1,2,3,4,5,6-Hexabromocyclohexane

    JAK2 inhibitor

    ≥98%
  • G4797

    GLYX-13 Trifluoroacetate

    Peptide; NMDA partial agonist.

    ≥98%
  • D3322

    Diflunisal

    NSAID; COX-1/2 inhibitor.

    ≥98%
  • C9200

    CX-6258

    Pim kinase inhibitor.

    ≥98%
  • B564086

    Boceprevir

    Inhibits HCV replication

    ≥98%
  • I530280

    INH1

    Hec1/Nek2 mitotic pathway inhibitor

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only